The impact of the COVID-19 on mediastinal lymph node examination in lung cancer surgery.

Abstract

At the start of the coronavirus disease 2019 (COVID-19) pandemic, the elective thoracic surgeries were postponed as much as possible. In recent days the pandemic has become more manageable and therefore an increase in the number of elective procedures is expected. However, there are still many uncertainties regarding the peroperative period. For example if patients with cancer become infected with COVID-19 in the postoperative period, information on the morbidity and mortality rates of these patients is insufficient.